U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Invasive Breast Lobular Carcinoma with Predominant In Situ Component

MedGen UID:
79008
•Concept ID:
C0279564
•
Neoplastic Process
Synonyms: Infiltrating Lobular Breast Carcinoma with Predominant In Situ Component; Invasive Lobular Breast Carcinoma with Predominant In Situ Component

Definition

A breast carcinoma characterized by the presence of a predominant lobular carcinoma in situ component and a minor component of invasive carcinoma. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVInvasive Breast Lobular Carcinoma with Predominant In Situ Component

Professional guidelines

PubMed

Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy.
Sinn HP, Anton HW, Magener A, von Fournier D, Bastert G, Otto HF
Eur J Cancer 1998 Apr;34(5):646-53. doi: 10.1016/s0959-8049(97)10106-x. PMID: 9713268

Recent clinical studies

Etiology

Factors influencing the hormone receptor and HER2 levels in breast cancer: a population-based analysis.
Tas F
Onkologie 2012;35(3):95-8. Epub 2012 Feb 21 doi: 10.1159/000336812. PMID: 22414972
Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges.
Tang F, Wei B, Tian Z, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Zhang H, Sahin A, Chen J, Bu H, Abraham S, Wu Y
Histopathology 2011 Jul;59(1):106-15. Epub 2011 Jun 13 doi: 10.1111/j.1365-2559.2011.03880.x. PMID: 21668471
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl 2003;(108):1-67. PMID: 12874968
Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy.
Ottesen GL, Christensen IJ, Larsen JK, Larsen J, Baldetorp B, Linden T, Hansen B, Andersen J
Breast Cancer Res Treat 2000 Apr;60(3):219-26. doi: 10.1023/a:1006453420088. PMID: 10930109
Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy.
Sinn HP, Anton HW, Magener A, von Fournier D, Bastert G, Otto HF
Eur J Cancer 1998 Apr;34(5):646-53. doi: 10.1016/s0959-8049(97)10106-x. PMID: 9713268

Diagnosis

The Christchurch Breast Cancer Patient Register: the first year.
Davey V, Robinson B, Dijkstra B, Harris G
N Z Med J 2012 Aug 24;125(1360):37-47. PMID: 22932653
Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges.
Tang F, Wei B, Tian Z, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Zhang H, Sahin A, Chen J, Bu H, Abraham S, Wu Y
Histopathology 2011 Jul;59(1):106-15. Epub 2011 Jun 13 doi: 10.1111/j.1365-2559.2011.03880.x. PMID: 21668471
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl 2003;(108):1-67. PMID: 12874968

Therapy

The Christchurch Breast Cancer Patient Register: the first year.
Davey V, Robinson B, Dijkstra B, Harris G
N Z Med J 2012 Aug 24;125(1360):37-47. PMID: 22932653

Prognosis

Factors influencing the hormone receptor and HER2 levels in breast cancer: a population-based analysis.
Tas F
Onkologie 2012;35(3):95-8. Epub 2012 Feb 21 doi: 10.1159/000336812. PMID: 22414972
Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy.
Sinn HP, Anton HW, Magener A, von Fournier D, Bastert G, Otto HF
Eur J Cancer 1998 Apr;34(5):646-53. doi: 10.1016/s0959-8049(97)10106-x. PMID: 9713268
Carcinoma arising within fibroadenomas of the breast. A clinicopathologic study of 105 patients.
Diaz NM, Palmer JO, McDivitt RW
Am J Clin Pathol 1991 May;95(5):614-22. doi: 10.1093/ajcp/95.5.614. PMID: 1850948

Clinical prediction guides

Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy.
Sinn HP, Anton HW, Magener A, von Fournier D, Bastert G, Otto HF
Eur J Cancer 1998 Apr;34(5):646-53. doi: 10.1016/s0959-8049(97)10106-x. PMID: 9713268
BRCA-associated breast cancer: absence of a characteristic immunophenotype.
Robson M, Rajan P, Rosen PP, Gilewski T, Hirschaut Y, Pressman P, Haas B, Norton L, Offit K
Cancer Res 1998 May 1;58(9):1839-42. PMID: 9581822
Carcinoma arising within fibroadenomas of the breast. A clinicopathologic study of 105 patients.
Diaz NM, Palmer JO, McDivitt RW
Am J Clin Pathol 1991 May;95(5):614-22. doi: 10.1093/ajcp/95.5.614. PMID: 1850948

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...